Japan Medical Dynamic Marketing, INC. (JMDMF) Comparison with companies in other sectors?

Japan Medical Dynamic Marketing, INC. has a share price of 31.27M. You can analyze Japan Medical Dynamic Marketing, INC. (JMDMF) competitors across different market sectors through stock heatmaps.

What are JMDMF's NET and operating margins?

Japan Medical Dynamic Marketing, INC. (JMDMF) operating margin is around N/A, and net profit margin is approximately N/A as of the latest reports.

In what way does JMDMF's earnings per share (EPS) trend reflect its financial momentum?

Japan Medical Dynamic Marketing, INC. (JMDMF) EPS is -0.22 (If EPS value is positive, then "signals consistent profit growth" if Negative then "signals consistent loss"). This metric is also critical in assessing valuation metrics like the P/E ratio for Japan Medical Dynamic Marketing, INC. is -13.68, and the company's ability to reinvest or distribute profits.

What does a high ROE mean for Japan Medical Dynamic Marketing, INC.?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Japan Medical Dynamic Marketing, INC. like P/E which is N/A, P/B which is N/A, and PEG which is N/A. Compare them with sector averages to evaluate if the stock is priced fairly.

Japan Medical Dynamic Marketing, INC.

JMDMF•PNK

Healthcare

Medical - Devices

$3.01

$0.00(0.00%)

U.S. Market opens in 14h 45m

Japan Medical Dynamic Marketing, INC. Fundamental Analysis

Japan Medical Dynamic Marketing, INC. (JMDMF) shows moderate financial fundamentals with a PE ratio of -13.68, profit margin of N/A, and ROE of N/A. The company generates N/A in annual revenue with moderate year-over-year growth of 8.35%.

Key Strengths

No significant strengths identified.

Areas of Concern

No major concerns flagged.

We analyze JMDMF's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 41.8/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

41.8/100

We analyze JMDMF's fundamental strength across five key dimensions:

Efficiency Score

Weak

JMDMF struggles to generate sufficient returns from assets.

ROA > 10%

N/A

Valuation Score

Moderate

JMDMF shows balanced valuation metrics.

PE < 25

-13.68

PEG Ratio < 2

N/A

Growth Score

Moderate

JMDMF shows steady but slowing expansion.

Revenue Growth > 5%

8.35%

EPS Growth > 10%

-1.36%

Financial Health Score

Weak

JMDMF carries high financial risk with limited liquidity.

Debt/Equity < 1

N/A

Current Ratio > 1

N/A

Profitability Score

Weak

JMDMF struggles to sustain strong margins.

ROE > 15%

N/A

Net Margin ≥ 15%

N/A

Positive Free Cash Flow

N/A

Key Financial Metrics

Is JMDMF Expensive or Cheap?

P/E Ratio

JMDMF trades at -13.68 times earnings. This suggests potential undervaluation.

-13.68

How Well Does JMDMF Make Money?

No data available.

Following the Money - Real Cash Generation

No data available.

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

N/A

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

N/A

vs 25 benchmark

P/B Ratio

Price to book value ratio

N/A

vs 25 benchmark

P/S Ratio

Price to sales ratio

N/A

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

N/A

vs 25 benchmark

Current Ratio

Current assets to current liabilities

N/A

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

N/A

vs 25 benchmark

ROA

Return on assets percentage

N/A

vs 25 benchmark

ROCE

Return on capital employed

N/A

vs 25 benchmark

How JMDMF Stacks Against Its Sector Peers

Metric	JMDMF Value	Sector Average	Performance
P/E Ratio	N/A	29.45	N/A
ROE	N/A	779.00%	N/A
Net Margin	N/A	-24930.00% (disorted)	N/A
Debt/Equity	N/A	0.26	N/A
Current Ratio	N/A	4.65	N/A
ROA	N/A	-19333.00% (disorted)	N/A

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Japan Medical Dynamic Marketing, INC.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

39.20%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-121.38%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

-61.59%

Industry Style: Defensive, Growth, Innovation

Declining

Japan Medical Dynamic Marketing, INC. Fundamental Analysis

Key Strengths

Areas of Concern

Fundamental Health Score

Efficiency Score

Valuation Score

Growth Score

Financial Health Score

Profitability Score

Key Financial Metrics

Is JMDMF Expensive or Cheap?

How Well Does JMDMF Make Money?

Following the Money - Real Cash Generation

Financial Ratios Analysis

Valuation Ratios

Financial Health

Efficiency Ratios

How JMDMF Stacks Against Its Sector Peers

Historical Growth Performance

5-Year Growth Trajectory

Fundamental Analysis FAQ

Japan Medical Dynamic Marketing, INC. (JMDMF) Comparison with companies in other sectors?

What are JMDMF's NET and operating margins?

In what way does JMDMF's earnings per share (EPS) trend reflect its financial momentum?

What does a high ROE mean for Japan Medical Dynamic Marketing, INC.?

How do I know if AAPL is overvalued or undervalued?